• Skip to primary navigation
  • Skip to main content
  • 786-300-3183
  • [email protected]
  • Facebook
  • Twitter
Florida Society of Anesthesiologists

Florida Society of Anesthesiologists

  • About FSA
    • FSA Leadership
      • Distinguished Service Award Past Recipients
      • President Engagement Award Past Recipients
      • FSA Past Presidents
    • FSA Staff
    • Calendar of Events
    • Contact FSA
    • FSA Charter & Bylaws
    • FSA Speakers Bureau
  • Annual Meeting
    • Meeting Info
    • Call For Abstracts
    • Past Posters
      • 2022 FSA Podium and Poster Abstracts
      • 2021 FSA Posters
      • 2020 FSA Posters
      • 2019 FSA Posters
      • 2018 FSA Posters
    • Past Meetings
      • 2022 Annual Meeting Recap
      • 2019 Annual Meeting Recap
      • 2018 Annual Meeting Recap
  • FSAPAC
    • Donate to FSAPAC
    • FSAPAC Donors for 2022
  • Join/Renew Membership
    • FSA Membership Renewal
    • Join the Florida Society of Anesthesiologists (FSA)
  • Member Login
  • Member Section

2020 FSA Posters

P051: SUCCESSFUL RE-IMPLANTATION OF SPINAL CORD STIMULATOR ONE YEAR AFTER DEVICE REMOVAL DUE TO INFECTION
Ruben Schwartz, DO1; Warren Southerland, MD2; Ivan Urits, MD2; Alan Kaye, MD3; Omar Viswanath, MD4; 1Mount Sinai Medical Center of Florida; 2Beth Israel Deaconness Medical Center; 3Louisiana State University Health Science Center; 4Valley Anesthesiology and Pain Consultants

Spinal cord stimulation (SCS) is an effective treatment modality for patients with chronic pain. SCS has demonstrated clinical benefit in patients with complex regional pain syndrome, failed back surgery syndrome, critical limb ischemia, and refractory angina pectoris. SCS therapy comes with the risk of potential complications including device failure, lead migration, loss of therapeutic paresthesia, and infection. For most clinicians, the management of these complications involves removal of the device and immediate re-implantation, except in the case of an infection. Although only seen in approximately 2.45% of SCS implants, infected devices are some of the most dreaded complications and add the risk of meningitis, epidural abscess, and vertebral osteomyelitis. It is crucial for physicians to recognize potential infections in a timely manner to prevent these more serious adverse effects. After explantation and initiation of antibiotic coverage, the question remains; what is the appropriate time to wait to re-implant? We briefly describe the case of the removal of an infected SCS device and successful re-implantation after a year. 

Copyright © 2023 Florida Society of Anesthesiologists ยท Managed by BSC Management, Inc.